N
NAUT
Nautilus Biotechnology Inc
0.71
-0.01-1.27%After Hours: 0.7125 -0.00 -0.01%16:32 08/15 EDT
OPEN/PREV CLOSE0.7390/0.7218
TODAY RANGE0.7100-0.7400
VOL153.85K
MARKET CAP90.01M
52 WEEK RANGE0.6600-3.090
AVG VOL (3M)304.64K
% TURNOVER0.12%
TURNOVER--
P/E (TTM)-1.3042
% RANGE4.16%
EPS(TTM)-0.5464
P/E(FORWARD)-1.2502
P/B0.4623
BVPS1.541
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP50.87M
SHARES OUTSTANDING126.31M
NEXT EARNINGS10/27-10/31
FREE FLOAT71.39M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/05 20:47
Nautilus Biotechnology jumps after Amazon discloses $1M stake
TipRanks·08/02 01:52
Nautilus Biotechnology’s Earnings Call: Progress Amid Challenges
TipRanks·08/01 12:05
Guggenheim Sticks to Its Buy Rating for Nautilus Biotechnolgy (NAUT)
TipRanks·08/01 05:25
Nautilus Biotechnology’s Q2 2025 Financial Highlights
TipRanks·07/31 20:25
Nautilus Biotechnolgy (NAUT) Gets a Buy from TD Cowen
Reuters·07/31 12:14
Nautilus Biotechnology Q2 net loss narrows as expenses drop
Seeking Alpha·07/31 12:13
Nautilus Biotechnology GAAP EPS of -$0.12
Reuters·07/31 12:00
BRIEF-Nautilus Biotechnology Q2 EPS USD -0.12
Reuters·07/31 12:00
NAUTILUS BIOTECHNOLOGY REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
Reuters·07/31 10:43
NAUTILUS BIOTECHNOLOGY Q2 OPERATING EXPENSES USD 17.097 MILLION
Benzinga·07/31 08:32
Earnings Scheduled For July 31, 2025
TipRanks·07/30 12:27
Nautilus Biotechnology enters agreement with Allen Institute
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.